Viewing Study NCT06030934


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2025-12-28 @ 11:53 PM
Study NCT ID: NCT06030934
Status: UNKNOWN
Last Update Posted: 2023-09-11
First Post: 2023-09-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module